140 related articles for article (PubMed ID: 28099903)
1. Talin-1 interaction network promotes hepatocellular carcinoma progression.
Chen P; Zheng X; Zhou Y; Xu Y; Zhu L; Qian Y
Oncotarget; 2017 Feb; 8(8):13003-13014. PubMed ID: 28099903
[TBL] [Abstract][Full Text] [Related]
2. Talin-1 correlates with reduced invasion and migration in human hepatocellular carcinoma cells.
Fang KP; Zhang JL; Ren YH; Qian YB
Asian Pac J Cancer Prev; 2014; 15(6):2655-61. PubMed ID: 24761880
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of the differentially expressed gene TNFRSF12A inhibits hepatocellular carcinoma cell proliferation and migration in vitro.
Wang T; Ma S; Qi X; Tang X; Cui D; Wang Z; Chi J; Li P; Zhai B
Mol Med Rep; 2017 Mar; 15(3):1172-1178. PubMed ID: 28138696
[TBL] [Abstract][Full Text] [Related]
4. The HOX gene network in hepatocellular carcinoma.
Cillo C; Schiavo G; Cantile M; Bihl MP; Sorrentino P; Carafa V; D' Armiento M; Roncalli M; Sansano S; Vecchione R; Tornillo L; Mori L; De Libero G; Zucman-Rossi J; Terracciano L
Int J Cancer; 2011 Dec; 129(11):2577-87. PubMed ID: 21626505
[TBL] [Abstract][Full Text] [Related]
5. Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell.
Fang KP; Dai W; Ren YH; Xu YC; Zhang SM; Qian YB
BMC Cancer; 2016 Jan; 16():45. PubMed ID: 26822056
[TBL] [Abstract][Full Text] [Related]
6. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs and genes contributing to the generation of cancer stem cells in hepatocellular carcinoma identified by RNA sequencing analysis.
Cao L; Zhang Q; Cheng S; Chen Z; Hua Z; Yang J; Liu D; Cui N
Oncol Rep; 2016 Nov; 36(5):2619-2624. PubMed ID: 27667473
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts.
Lin ZY; Chuang WL
Kaohsiung J Med Sci; 2013 Jun; 29(6):312-8. PubMed ID: 23684136
[TBL] [Abstract][Full Text] [Related]
9. Identification of AKT kinases as unfavorable prognostic factors for hepatocellular carcinoma by a combination of expression profile, interaction network analysis and clinical validation.
Zhang Y; Guo X; Yang M; Yu L; Li Z; Lin N
Mol Biosyst; 2014 Feb; 10(2):215-22. PubMed ID: 24247267
[TBL] [Abstract][Full Text] [Related]
10. OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.
Li H; Zhang J; Lee MJ; Yu GR; Han X; Kim DG
Oncotarget; 2017 Mar; 8(11):18129-18144. PubMed ID: 28184024
[TBL] [Abstract][Full Text] [Related]
11. Identification of hepatocellular carcinoma-associated hub genes and pathways by integrated microarray analysis.
Liu F; Li H; Chang H; Wang J; Lu J
Tumori; 2015; 101(2):206-14. PubMed ID: 25768320
[TBL] [Abstract][Full Text] [Related]
12. Co-expression network analysis identified six hub genes in association with metastasis risk and prognosis in hepatocellular carcinoma.
Chen P; Wang F; Feng J; Zhou R; Chang Y; Liu J; Zhao Q
Oncotarget; 2017 Jul; 8(30):48948-48958. PubMed ID: 28430663
[TBL] [Abstract][Full Text] [Related]
13. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
14. Identification by differential tissue proteome analysis of talin-1 as a novel molecular marker of progression of hepatocellular carcinoma.
Kanamori H; Kawakami T; Effendi K; Yamazaki K; Mori T; Ebinuma H; Masugi Y; Du W; Nagasaka K; Ogiwara A; Kyono Y; Tanabe M; Saito H; Hibi T; Sakamoto M
Oncology; 2011; 80(5-6):406-15. PubMed ID: 21846996
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic analysis of a transgenic zebrafish hepatocellular carcinoma model reveals a prominent role of immune responses in tumour progression and regression.
Li Z; Luo H; Li C; Huo X; Yan C; Huang X; Al-Haddawi M; Mathavan S; Gong Z
Int J Cancer; 2014 Oct; 135(7):1564-73. PubMed ID: 24550086
[TBL] [Abstract][Full Text] [Related]
16. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY
Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662
[TBL] [Abstract][Full Text] [Related]
19. Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells.
Lin ZY; Chuang WL
Biomed Pharmacother; 2012 Sep; 66(6):454-8. PubMed ID: 22681909
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
Likhitrattanapisal S; Tipanee J; Janvilisri T
Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
